Most hemorrhoids are not permanent. Acute symptomatic episodes resolve in 7 to 14 days with conservative care in roughly 80 percent of cases, and the enlarged vascular cushions themselves never fully disappear because they are normal anatomy. What does persist is the underlying tissue laxity and venous pressure pattern that caused the flare. Roughly 50 percent of people experience a recurrence within 5 years, which is why permanent resolution depends on changing the mechanical load on the anal cushions rather than on any single treatment. Small residual skin tags and external clots may remain indefinitely, but the pain, bleeding, and swelling of an active episode usually do not.

The vascular cushion mechanism: why hemorrhoids exist at all

Everyone has hemorrhoids. The anal canal contains three to four submucosal vascular cushions positioned at the left lateral, right anterior, and right posterior positions in about 60 to 70 percent of people. These cushions are functional anatomy, not pathology. They fill with blood, act as a plug that maintains continence at rest, and help distinguish gas from stool. When researchers describe hemorrhoids as "permanent," they are usually describing these cushions.

Disease begins when the cushions become engorged, stretched, and displaced. The submucosal connective tissue that anchors them to the anal wall degrades with age, with chronic straining, and with prolonged increases in intra-abdominal pressure. As collagen and elastin fibers fragment, the cushions slide downward. This sliding is the accepted mechanism behind internal hemorrhoid grade progression, from grade I (no prolapse) through grade IV (irreducible prolapse).

The venous anatomy matters here. The superior rectal vein drains into the portal system without valves. That valveless segment means pressure from the abdomen transmits directly to the anal cushions. A chronic cough, heavy lifting, or a pregnancy at 30 weeks all raise that pressure column. In plain terms: hemorrhoids are not varicose veins in the classic sense, and the old "valve failure" story is oversimplified.

Subtle correction to a common belief: hemorrhoids are not caused by sitting on cold concrete, and they are not caused by spicy food in most people. Both are folklore that has survived because symptoms fluctuate.

How long an episode lasts: timeline by grade

Symptom duration depends almost entirely on hemorrhoid grade and whether thrombosis occurred. The table below reconciles the ranges you will see quoted elsewhere, which often conflict because they mix internal and external disease.

Hemorrhoid type Typical peak Pain resolves Swelling or lump resolves Bleeding stops
Grade I internal (bleeding only) Day 1 to 2 Not applicable Not applicable 3 to 7 days
Grade II internal (prolapse reduces) Day 2 to 3 3 to 5 days 5 to 10 days 5 to 10 days
Grade III internal (manual reduction) Day 2 to 4 5 to 7 days 10 to 21 days 7 to 14 days
Thrombosed external 48 hours 7 to 10 days 2 to 6 weeks (skin tag may persist) Rare
Post-banding (rubber band) Day 2 to 4 2 to 5 days Not applicable Not applicable
Post-surgical (hemorrhoidectomy) Day 3 to 5 1 to 3 weeks 4 to 8 weeks Not applicable

The most contested number in the literature is the recurrence rate after office procedures. Rubber band ligation carries a 15 to 20 percent recurrence at 1 year and roughly 30 percent by 5 years. Excisional surgery recurs in under 5 percent at 5 years but carries a 1 to 5 percent risk of incontinence to flatus and a 5 to 10 percent risk of wound complications. These two numbers pull in opposite directions, which is exactly why grade and patient priorities drive the choice.

Internal versus external: why one goes away and the other leaves a mark

Internal hemorrhoids sit above the dentate line, where visceral nerve supply means they rarely cause sharp pain. They bleed and prolapse. Because the mucosa above the dentate line regenerates quickly, a healing internal hemorrhoid returns to a near-normal appearance once inflammation subsides. The cushion stays, but the swelling and bleeding stop.

External hemorrhoids sit below the dentate line and are covered by skin innervated by somatic pain fibers. This is why a thrombosed external hemorrhoid is one of the most painful benign conditions in medicine, often rated 7 to 9 out of 10 at peak. When the clot resolves, the stretched skin does not always return to its prior contour. A residual skin tag remains in roughly 30 to 40 percent of thrombosed external cases.

Here is the counterintuitive mechanism: the pain of a thrombosed external hemorrhoid often peaks at 48 hours and then declines sharply, not because the clot dissolves but because the overlying skin necroses and the pressure releases. That is why conservative management of a thrombosed external hemorrhoid is measured in days, while the lump itself persists for weeks. If a patient presents within 72 hours of symptom onset, excision under local anesthetic provides faster relief than watchful waiting, per the 2018 American Society of Colon and Rectal Surgeons clinical practice guidelines.

Grades, risk factors, and who actually keeps them

Grade is the single strongest predictor of whether hemorrhoids become a recurring problem.

  • Grade I: bleeding without prolapse. About 40 percent of symptomatic patients.
  • Grade II: prolapse that reduces spontaneously. Roughly 30 percent.
  • Grade III: prolapse requiring manual reduction. About 20 percent.
  • Grade IV: irreducible prolapse. Under 10 percent.

Symptomatic hemorrhoids affect an estimated 4.4 percent of US adults at any time and roughly 10 million people annually, though prevalence rises to 38 percent on colonoscopy screening in adults over 45. Peak incidence falls between ages 45 and 65. Pregnancy raises risk substantially: about 25 to 35 percent of pregnant women report symptomatic hemorrhoids, most commonly in the third trimester and in the first 24 hours postpartum.

The non-obvious driver is not fiber alone. A 2018 meta-analysis of fiber supplementation found a 47 percent reduction in persistent symptoms, but only for fiber taken consistently for at least 6 weeks. The benefit came from softer stool consistency, not from stool frequency. People who take fiber only during flares get a fraction of that benefit.

Constipation affects roughly 16 percent of adults globally, per 2020 data from the World Health Organization's global health estimates, and it is the most modifiable risk factor. Others include prolonged toilet sitting beyond 5 minutes, low physical activity, and a low-fiber diet under 15 grams daily against a recommended 25 to 30 grams.

The comparison that matters: treatment trade-offs

Choosing between watchful waiting, office procedures, and surgery is a decision about recurrence versus risk. The table below is the comparison most thin explainers skip.

Option Best for Recurrence at 5 years Key drawback Typical cost (US)
Fiber and lifestyle alone Grades I to II 40 to 50 percent Slow onset, 4 to 6 weeks USD 30 to 60 per month
Rubber band ligation Grades II to III About 30 percent Post-procedure pain in 5 to 10 percent USD 400 to 1,200
Sclerotherapy Grade I to II 30 to 40 percent Lower efficacy than banding USD 300 to 800
Doppler-guided ligation Grades II to III 15 to 25 percent Limited availability, higher cost USD 1,500 to 3,500
Excisional surgery Grades III to IV Under 5 percent 1 to 3 weeks of significant pain USD 4,000 to 8,000

The number that surprises most readers: recurrence is not a sign of failed treatment. It reflects that the underlying cushion and tissue laxity remain. Any procedure removes tissue but does not restore connective tissue elasticity.

Misconceptions that keep people from getting relief

The most persistent misconception is that hemorrhoids are caused by sitting too long on hard surfaces. A 2021 review found no consistent association with surface hardness. What matters is duration of straining and intra-abdominal pressure.

A second misconception: bleeding hemorrhoids and colorectal cancer are easy to tell apart. They are not. Roughly 90 percent of rectal bleeding in adults under 45 is attributable to benign anorectal disease, but above age 45 the probability shifts. Anyone over 45 with new rectal bleeding should be evaluated for colorectal cancer regardless of hemorrhoid history. The mechanism is that both conditions can present with identical bright red blood.

A third: surgery is the only permanent fix. Excisional surgery has under 5 percent recurrence, but lifestyle change after surgery still determines long-term comfort. Patients who do not address straining behavior redevelop symptoms in adjacent tissue.

What to actually do: concrete steps that change the timeline

The evidence supports a layered approach, and timing matters as much as the intervention. Acute care targets the first 72 hours. Maintenance care targets the following 6 weeks.

  • Start fiber at 25 to 30 grams daily and hold it for at least 6 weeks; the 47 percent symptom reduction in trials came only with sustained use.
  • Limit toilet sitting to 5 minutes and avoid phone use on the toilet, which extends sitting time in about 40 percent of adults according to observational studies.
  • Use warm sitz baths at 40 to 42 degrees Celsius for 10 to 15 minutes, up to 3 times daily, during acute flares.
  • Keep stool soft and hydrated; aim for 1.5 to 2 liters of fluid daily unless medically restricted.
  • Do not delay evaluation if bleeding persists beyond 7 days or occurs without pain.

Red-flag symptoms that require prompt medical assessment:

  • Bleeding that is dark, maroon, or mixed with stool rather than coating the surface
  • Unexplained weight loss of more than 4.5 kilograms (10 pounds) over 6 months
  • A hard, fixed, or irregular mass rather than a soft compressible lump
  • Fever with anal pain, which may indicate abscess rather than hemorrhoid
  • Symptoms that continue unchanged past 14 days of conservative care

Over-the-counter topical products deserve a note. Hydrocortisone creams above 1 percent should not be used beyond 7 days, per US Food and Drug Administration labeling, because prolonged use thins the anal skin. The American Gastroenterological Association 2022 guidance does not recommend routine topical anesthetics for internal disease, since they do not reach the affected tissue.

Limits of what we know

Two areas remain genuinely uncertain. First, the long-term benefit of preventive lifestyle change after a procedure is poorly quantified; no large trial has followed post-surgical patients across 10 years. Second, the role of pelvic floor physical therapy in hemorrhoid recurrence is promising but lacks randomized data. The mechanism is plausible, since pelvic floor dyssynergia contributes to straining in up to 20 percent of patients with refractory constipation, but evidence is thin.

One number is settled: the cushions themselves are permanent, the disease is not. Treatment success should be measured by symptom control and recurrence interval, not by the hope of erasing normal anatomy. That reframing alone changes what patients expect and what they comply with.